In Barcelona, Spain, INBRAIN Neuroelectronics, a company specializing in brain-computer interface therapeutics (BCI-Tx) using graphene-based neural technologies, has revealed a new collaboration with Microsoft. The aim is to investigate the application of agentic artificial intelligence (AI) driven by Microsoft’s cloud and data infrastructure for enhancing real-time precision neurology and advancing next-generation brain-computer interface (BCI) therapeutics. This partnership seeks to harness Microsoft’s Azure AI infrastructure for this purpose.